PDCD1 and neoplasm: As shown in Figure 6B,C, the combination of CH‐OD‐SSZ hydrogel and anti‐PD‐1 significantly reduced tumor burden and prolonged survival time in comparison to CH‐OD‐SSZ hydrogel or anti‐PD‐1 alone.